Sapphire Star Partners’s Abiomed Inc ABMD Stock Holding History

Sapphire Star Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$296K	Sell	910 -3,378	-79%	-$1.17M	0.4%	83
2018 Q3	$1.93M	Sell	4,288 -957	-18%	-$377K	1.93%	10
2018 Q2	$2.15M	Buy	5,245 +250	+5%	+$90.6K	2.21%	8
2018 Q1	$1.45M	Sell	4,995 -3,870	-44%	-$981K	1.61%	14
2017 Q4	$1.66M	Buy	8,865 +5,414	+157%	+$1.01M	1.97%	11
2017 Q3	$582K	Sell	3,451 -841	-20%	-$127K	0.75%	33
2017 Q2	$615K	Buy	4,292 +176	+4%	+$23.7K	0.78%	26
2017 Q1	$515K	Sell	4,116 -773	-16%	-$89.6K	0.59%	34
2016 Q4	$551K	Buy	4,889 +1,838	+60%	+$213K	0.61%	30
2016 Q3	$391K	Buy	+3,051	New	+$365K	0.47%	32
2016 Q2	–	Sell	-3,215	Closed	-$290K	–	82
2016 Q1	$290K	Hold	3,215	–	–	0.23%	62
2015 Q4	$290K	Buy	+3,215	New	+$273K	0.38%	41

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sapphire Star Partners's ABMD Position: Q4 2018 in Review

Sapphire Star Partners reduced its Abiomed Inc (ABMD) stake by 79% in Q4 2018, selling an estimated $1.17M and leaving 910 shares worth $296K. The position accounts for 0.4% of the portfolio, ranked #83.

Sapphire Star Partners first reported a position in ABMD in Q4 2015 and has held it in 12 quarters since. The position peaked at $2.15M in Q2 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

Sapphire Star Partners held 910 shares of Abiomed Inc worth $296K as of Q4 2018.
Sapphire Star Partners sold 3,378 Abiomed Inc shares in Q4 2018, an estimated $1.17M.
Abiomed Inc made up 0.4% of Sapphire Star Partners's portfolio in Q4 2018, its #83 holding.
Sapphire Star Partners first reported a position in Abiomed Inc in Q4 2015 and has held it in 12 quarters since.
Sapphire Star Partners's Abiomed Inc position peaked at $2.15M in Q2 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.